The Cardiovascular Care Group (TCVCG), announced today it has united with The Vein Institute of New Jersey to offer patients access to an expanded team of highly skilled clinicians with outstanding results and additional locations throughout Central and Northern New  Jersey. Reinforcing its commitment to producing great outcomes for the millions of Americans who have varicose and spider veins, the merger increases the number of board–certified physicians available to patients further enabling The Vein Institute at TCVCG to meet the growing demand for its services.

“Through combining our well–respected practices, we can now provide our patients with even greater comfort and convenience as they receive treatment for vascular conditions,” said Clifford Sales, M.D., of The Cardiovascular Care Group. “We are confident that patients will immediately benefit from our merger with The Vein Institute of New Jersey as it shares in our personalized and unique care model that requires patients to be evaluated and treated by board–certified physicians within our specialty, which makes our practice truly one-of-a-kind in the State.”  

The newly integrated board–certified physician team of The Vein Institute at TCVCG tailors specific treatment to each patient to ensure that the best and most appropriate care is provided. Individuals who are prime candidates for The Vein Institute at TCVCG’s services are those with veins that are cosmetically unappealing, or cause pain or other symptoms.  

“The Vein Institute naturally complements and enhances the TCVCG team, which is why the merger made sense and was the next natural step for us as we aim to continue to provide the high-quality treatment and care our growing patient base has come to expect from us,” said Michael Ombrellino, M.D., of The Vein Institute. “We believe there will be a number of beneficial and synergistic opportunities that our unification creates both internally and for our patients.”  

An especially unique aspect of The Vein Institute at TCVCG that will be beneficial to patients is the breadth of vein treatments. Unlike most practices that offer limited options, The Vein Institute at TCVCG provides a multitude of treatment modalities – all of which can be performed in the office in less than 20 minutes, allowing patients to resume full activity the same day. The treatments include:

• Sclerotherapy: A relatively painless procedure in which the doctor injects a small amount of fluid into the affected area, causing the vein to collapse and disappear.
• Ablation: A minimally invasive alternative to stripping where the vein causing problems with venous circulation is removed non-surgically.
• Microphlebectomy: Use of tiny incisions to remove larger veins that are not amenable to injections.
• Laser Therapy: Use of a laser to remove a small surface vein from the leg, face or breast.  

Beyond the breadth of vascular treatment options available and the highly personalized care delivered,  The Vein Institute at TCVCG affords a comfortable and calming environment for patients. From the moment patients step inside any one of the seven centers, located in Westfield, Springfield, Morristown, Clifton, Princeton, Shrewsbury and Sparta, they are personally greeted and welcomed into a tranquil and peaceful spa-like environment.  

Dr. Sales added, “By combining our extremely talented teams, we are positioned for even further growth in the future. The merger enables us to increase our internal efficiencies and offer our patients a wider range of state-of-the-art care options, thus enhancing our role as New Jersey’s top-rated vein specialists.”